最後更新 2024-05-18 07:31:35 (UTC+8)

基本分析

透過季節調整季營收,判斷美股整體趨勢,但注意股價有時候領先基本面的數據,應搭配其他領先指標判斷。

季營收趨勢 tooltip

季節調整季營收
季增率

-1.3%


截至2023-12-31

基本資料

個股的基本資料,以及所屬的類股和產業。

公司介紹

業務介紹

Smith & Nephew plc及其子公司在全球範圍內開發、製造、銷售醫療器械。該公司提供膝關節植入產品,用於膝關節置換手術;髖關節植入產品,用於髖關節重建;以及創傷和四肢產品,包括用於穩定嚴重骨折和矯正手術的內部和外部裝置。它還為外科醫生提供運動醫學關節修復產品,包括進行關節微創手術所需的儀器、技術和植入物,例如修復軟組織損傷和膝、髖、肩的退行性疾病,以及半月板修復系統。此外,該公司還提供關節鏡手術輔助技術,包括用於手術進入的液體管理設備、高清攝像機、數字圖像捕獲、鏡頭、光源和監視器,以協助關節內部的可視化,射頻、電機和機械組織切除設備,以及用於切除損壞組織的手術器械;以及耳鼻喉解決方案。此外,它還提供用於治療和預防急性和慢性傷口的先進傷口護理產品,包括腿部、糖尿病和壓力性潰瘍、燒傷和手術後傷口;先進傷口生物活性產品,包括生物製劑和其他生物活性技術,用於去除壞死組織和皮膚修復/再生,以及再生醫學產品,包括皮膚、骨移植和關節軟骨替代品;以及先進傷口設備,例如傳統和一次性負壓傷口治療和水刀手術系統。它主要為醫療保健提供者提供服務。Smith & Nephew plc成立於1856年,總部位於英國沃特福德。

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures. It also provides sports medicine joint repair products for surgeons, including instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder, as well as meniscal repair systems. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, including biologics and other bioactive technologies for debridement and dermal repair/regeneration, as well as regenerative medicine products including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It primarily serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.

所屬產業

所屬類股
Healthcare
所屬產業
Medical - Devices

警語

1. 資料僅供參考,不做任何獲利保證及特定股票與點位推薦建議。

2. 資料並不完整,需要完整資料請至相關網站索取。

3. 任何股市數據分析皆存在倖存者偏差。

warning